J&J: acquires V-Wave
(CercleFinance.com) - Johnson & Johnson announces that it has completed the acquisition of V-Wave, a privately-held company specializing in innovative treatments for heart failure.
V-Wave joins Johnson & Johnson MedTech, strengthening its position in cardiovascular diseases.
This acquisition supports the company's strategy of investing in high-growth markets and complements its medical technology portfolio.
V-Wave's Ventura Interatrial Shunt implant offers tremendous promise for heart failure patients, it said.
The transaction will result in a charge of $600m in Q4 2024.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
V-Wave joins Johnson & Johnson MedTech, strengthening its position in cardiovascular diseases.
This acquisition supports the company's strategy of investing in high-growth markets and complements its medical technology portfolio.
V-Wave's Ventura Interatrial Shunt implant offers tremendous promise for heart failure patients, it said.
The transaction will result in a charge of $600m in Q4 2024.
Copyright (c) 2024 CercleFinance.com. All rights reserved.